May 2014

3D CMR comparable to MPS for estimating ischemic burden ()
SCAI.14: Bleeper warning helps reduce operator radiation exposure by third ()
SCAI.14: ORBIT II maintains benefits while shaving costs ()
Hospital pays $41M to settle overstenting case ()
eCardio and Yocaly will jointly advance remote cardiac monitoring in the United States ()
Severe heart failure may put patients at risk for diabetes ()
Doctor data release: A small step forward amid missteps ()
Medtronic pays $9.9M to settle kickback claims ()
Spotlight on guidelines ()
1 in 3 patients don’t fill clopidogrel script soon after PCI ()
CardioMEMS gets FDA approval and buyout offer ()
Deal lets Volcano add PAD device to its portfolio ()
Spectranetics acquires balloon catheter company ()
Boehringer earmarks $650M to settle Pradaxa suits ()
ACE board members lead sessions in the Cath Lab Leadership Boot Camp at SCAI 2014 Scientific Sessions ()
Class 1 lesson: 20 percent of guideline recommendations revised ()
Cardiologist fatally shot on volunteer mission ()
Discovering gold in chest CTs: Incidental findings inform risk score ()
Temple scientists receive $11.5 million grant for heart failure research ()
Nine-month results of VISIBILITY Iliac study presented at EuroPCR 2014 ()
Expanding surgical measures to understand CV service lines ()
Maquet recalls intra-aortic balloon pump ()
FDA gives PE ultrasound device a green light ()
MRI algorithm may ID stroke patients at risk of major bleeding ()
Temporary reduction in BMI provides cardiovascular benefit ()
TAVR triumphs ()
Tufts University names Dariush Mozaffarian as dean of Friedman School of Nutrition Science and Policy ()
Boston Scientific Lotus Valve System demonstrates strong performance and safety profile at six months ()
Abiomed receives Continuous Access Protocol (CAP) for RECOVER RIGHT Impella RP study ()
Medtronic CoreValve System demonstrates positive clinical performance at two years in 'real world' ADVANCE study ()
Sanford-Burnham and Daiichi Sankyo form alliance to study novel drug targets in cardiovascular-metabolic diseases ()
Medtronic announces CE mark and launch of NC Euphora coronary balloon ()
Accreditation for Cardiovascular Excellence (ACE) accredits academic medical center renowned as the birthplace of percutaneous coronary intervention (PCI) ()
Playing doctor: Online game improves blood pressure treatment ()
DIY PAD therapy: Home-based exercise program improves mobility ()
Declining use of cardiac service lines reflects shift to outpatient services ()
HF patients change resuscitation preferences near end of life ()
Swift treatment, less use of anesthesia lowers stroke cost ()
National heart organizations join to combat the global hypertension epidemic ()
TAVR détente: Edwards, Medtronic settle patent dispute ()
Afib hospitalizations, costs leap higher over decade ()
Stress CMR predicts heart disease risk in obese patients ()
FDA recalls tainted blood pressure injectable ()
Compounding center offers $100M compensation fund ()
CMS supports coverage for transcatheter mitral devices ()
St. Jude Medical Aanounces first implants in US study of the Portico Transcatheter Aortic Heart Valve System ()
Pioneering study by award-winning Children’s Hospital of Michigan and Wayne State University researcher shows many kids with cardiomyopathy can regain heart health ()
SynCardia Total Artificial Heart with SynHall valves receives CE mark ()
FDA says ‘no’ to serelaxin for heart failure ()
Alert flags patients at risk of drug-induced fatal arrhythmia ()
Boston Scientific snags Bayer’s peripheral unit for $415M ()
ACC to imagers: Here’s a chance to get involved ()
A brighter job picture ()
Elixir Medical receives CE Mark approval for the breakthrough fully bioresorbable DESolve 100 Novolimus Eluting Coronary Scaffold System ()
Starting pay better in cardiology than in other fields ()
Groundbreaking cardiology system earns “Stage 2” certification ()
Sleeper in Seattle: A standout for hypertension ()
Getting pragmatic ()
FDA study weighs in favor of dabigatran ()
Therapy sought to reduce major risk from minor bleeding that can follow stroke ()
Tunnel vision? Many high-risk patients not prescribed statins ()
Feds scrutinizing two cardiac device makers ()
Boehringer Ingelheim will make detailed clinical trial data available to the scientific community ()
Struggling with statins ()
Low-value cardiac services take bite from Medicare ()
HRS.14: ACE inhibitors, ARBs lower incidence of appropriate shocks ()
New data show that defibrillators programmed to wait longer to deliver therapy are safe for secondary prevention ICD patients with Medtronic SmartShock technology ()
Late-breaking clinical trial results show Medtronic-exclusive pacemaker algorithm significantly delays atrial fibrillation ()
Study of Boston Scientific Latitude Remote Patient Management System presented at Heart Rhythm 2014 demonstrates significant reduction in mortality and hospitalization ()
Study results show significant overall cost savings with St. Jude Medical Quadripolar System ()
HRS.14: CRT-D longevity varies across device makers ()
HRS.14: Testing ICDs during implantation isn’t necessary ()
FDA clears vorapaxar to reduce MI, stroke risks ()
Nixing copays for heart drugs improves outcomes for nonwhite patients ()
Readmissions: All things great and small ()
Beta-blocker blues: Quality in question ()
Post-CABG care program lowers readmissions, costs ()
Hospital readmissions continue to trend down ()
Inaccurate INR results prompt recall of test strips ()
FDA OKs MRI-compatible pacemaker technology ()
Lipid society sides with LDL targets in draft guidelines ()
SCAI.14: Putting Google Glass in your tool kit ()
‘Factory-managed’ care raises quality, cuts costs in cardiac surgery ()
Biotronik portfolio expanded with Fortress Introducer Sheath for peripheral interventions ()
Gender gap in statin trials? ()
FDA denies upgrade in aspirin’s labeling ()
Revised guidelines help reduce risk of recurrent strokes ()
CMS puts index hospitals on hook for CABG readmissions ()
Shining a light on heart disease ()
Minneapolis Heart Institute Foundation announces its first implant of world's smallest cardiac pacemaker ()
FDA rejects bid to market cangrelor ()
One third of heart disease, stroke deaths potentially preventable ()
AATS: Robotic valve procedures may not be a bargain ()
Robotics in the Cath Lab: The Time is Now ()
Medtronic Viva cardiac resynchronization therapy-pacemaker now available in Europe ()
Accreditation for Cardiovascular Excellence (ACE) speaker Sheree Schroeder presents: A team based approach for billing ()
Abbott's first-of-its-kind MitraClip device now approved in Canada ()
HeartWare: Monitor VAD batteries ()
Ablation & Afib: Zapping Barriers to Success ()
Cautious Optimism ()
Renal Denervation: Beginning of the End or End of the Beginning? ()
Heart Team Approach: Still a Work in Progress ()
Continents & conferences ()